Treatment Outcomes with Hypomethylating Agents and Venetoclax for AML in the Community Compared to an Academic Setting

被引：0
|
作者：
Jeffrey, Lantz, Jr. [1 ]
Pham, Natalie [2 ]
Jones, Caroline [3 ]
Kundu, Debamita [4 ]
McCann, Nicholas [5 ]
El Chaer, Firas [1 ]
Reed, Daniel [1 ]
Keng, Michael [1 ]
机构：
[1] Univ Virginia, Div Hematol & Oncol, Dept Med, Comprehens Canc Ctr,Med Ctr, Charlottesville, VA USA
[2] Univ Virginia, Dept Med, Med Ctr, Charlottesville, VA USA
[3] Univ Virginia, Dept Pharm, Med Ctr, Charlottesville, VA USA
[4] Univ Virginia, Div Biostat, Charlottesville, VA USA
[5] Univ Virginia, Sch Med, Charlottesville, VA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinical outcomes of patients receiving venetoclax and hypomethylating agents for AML in academic and academic-community partnerships
    Pham, Natalie
    Lantz, Jeffrey
    Jones, Caroline
    Kundu, Debamita
    McCann, Nicholas
    El Chaer, Firas
    Reed, Daniel
    Keng, Michael Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US
    Vachhani, Pankit
    Flahavan, Evelyn M.
    Xu, Tao
    Ma, Esprit
    Montez, Melissa
    Gershon, Anda
    Onishi, Maika
    Jin, Huan
    Ku, Grace
    Flores, Brannon
    Bui, Cat N.
    Abbas, Jonathan A.
    Donnellan, William
    ONCOLOGIST, 2022, 27 (11): : 907 - 918
  • [3] Results of Treatment With Hypomethylating Agents Versus Hypomethylating Agents/Venetoclax in Patients With AML Single-Center Experience
    Patino, Ana Flavia
    Brulc, Erika
    Conca, Alberto Gimenez
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S289 - S289
  • [4] The highs and lows of venetoclax with hypomethylating agents for refractory AML
    Brunner, Andrew M.
    LEUKEMIA RESEARCH, 2020, 91
  • [5] Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML
    Shimony, Shai
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Liu, Yiwen
    Schaefer, Eva J.
    Zeidan, Amer M.
    Goldberg, Aaron D.
    Stein, Eytan M.
    Marcucci, Guido
    Lindsley, R. Coleman
    Chen, Evan C.
    Perez, Jorge Ramos
    Stein, Anthony
    DeAngelo, Daniel J.
    Neuberg, Donna S.
    Stone, Richard M.
    Ball, Brian
    Stahl, Maximilian
    LEUKEMIA, 2024, 38 (04) : 762 - 768
  • [6] Real-world management and outcomes for newly diagnosed AML patients initiating venetoclax and hypomethylating agents in US community practice
    Mcneill, Ann Marie
    Wang, Yuexi
    Doran, Charlotte
    Cain, Lauren E.
    Liu, Yangyang
    Lan, Ziyu
    Cheng, Wei-Han
    Pullarkat, Vinod
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 334 - 334
  • [7] Healthcare Disparities Among Minorities Treated with Venetoclax and Hypomethylating Agents in AML
    Bouligny, Ian M.
    Murray, Graeme
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Maher, Keri
    BLOOD, 2022, 140 : 13305 - 13306
  • [8] Efficacy of Hypomethylating Agents with Venetoclax in TP53mut AML
    Bouligny, Ian M.
    Murray, Graeme
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Maher, Keri
    BLOOD, 2022, 140 : 11842 - 11843
  • [9] Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)
    Arslan, Shukaib
    Zhang, Jianying
    Dhakal, Prajwal
    Moran, Jenna A.
    Naidoo, Nuthana
    Story, Jennifer Lombardi
    Pullarkat, Vinod A.
    Stein, Anthony S.
    Marcucci, Guido
    Yaghmour, George
    Bhatt, Vijaya R.
    Fathi, Amir T.
    Aldoss, Ibrahim
    BLOOD, 2020, 136
  • [10] Venetoclax Plus Hypomethylating Agents for Relapsed/Refractory Acute Myeloid Leukemia (AML) Is Safe and Manageable in the Outpatient Setting
    Nanni, Jacopo
    Papayannidis, Cristina
    Cristiano, Gianluca
    Marconi, Giovanni
    Sartor, Chiara
    Parisi, Sarah
    Ottaviani, Emanuela
    Baldini, Lorenza
    Testoni, Nicoletta
    Baldazzi, Carmen
    Ricci, Paolo
    Bezzi, Chiara Di Giovanni
    Abd-alatif, Rania
    Paolini, Stefania
    Cavo, Michele
    Curti, Antonio
    BLOOD, 2020, 136
12345